Stock Market News
U.S. CDC closes investigation on Abbott’s infant formula
2022.05.13 20:01
FILE PHOTO: Abbott Laboratories logo is displayed on a screen at the New York Stock Exchange (NYSE) in New York City, U.S., October 18, 2021. REUTERS/Brendan McDermid/File Photo
(Reuters) – The U.S. Centers for Disease Control and Prevention (CDC) has closed its investigation on Abbott Laboratories (NYSE:ABT)’ infant formula, with no additional cases of infections, according to a notice on the U.S. Food and Drug Administration website.
The agencies were investigating bacterial infections caused by the infant formula manufactured at Abbott’s Sturgis facility in Michigan.
